Lars Wilkinson

600 total citations
23 papers, 450 citations indexed

About

Lars Wilkinson is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Lars Wilkinson has authored 23 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Lars Wilkinson's work include Growth Hormone and Insulin-like Growth Factors (7 papers), Diabetes Treatment and Management (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Lars Wilkinson is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (7 papers), Diabetes Treatment and Management (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Lars Wilkinson collaborates with scholars based in Denmark, United Kingdom and United States. Lars Wilkinson's co-authors include Shaun Walsh, Giuseppe Mazza, Charlotte Camp, Liz Carroll, Jamie O’Hara, Joseph Marcus, Sydney L. Hans, Meryl Brod, Hrvoje Vražić and Lise Højbjerre and has published in prestigious journals such as Diabetes, Schizophrenia Bulletin and Quality of Life Research.

In The Last Decade

Lars Wilkinson

22 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Wilkinson Denmark 11 180 124 114 90 76 23 450
Miranda Pans Belgium 10 160 0.9× 24 0.2× 102 0.9× 244 2.7× 49 0.6× 10 493
Maja Miloslavsky United States 5 80 0.4× 77 0.6× 22 0.2× 235 2.6× 17 0.2× 10 399
Hanan Azzam Egypt 11 26 0.1× 63 0.5× 45 0.4× 92 1.0× 77 1.0× 44 337
Kung‐Ting Kao Australia 13 98 0.5× 6 0.0× 55 0.5× 35 0.4× 54 0.7× 25 368
Julie M. Cessna United States 8 42 0.2× 25 0.2× 20 0.2× 43 0.5× 87 1.1× 8 361
Yunwen Xu United States 10 46 0.3× 13 0.1× 29 0.3× 70 0.8× 28 0.4× 32 301
Jesse Fishman United States 10 68 0.4× 39 0.3× 13 0.1× 119 1.3× 102 1.3× 50 405
Dennis Meletiche United States 10 30 0.2× 34 0.3× 15 0.1× 218 2.4× 23 0.3× 13 514
Eleni Ι. Kalogirou Cyprus 8 131 0.7× 95 0.8× 19 0.2× 54 0.6× 67 0.9× 13 413
K Segnestam Sweden 6 138 0.8× 14 0.1× 51 0.4× 10 0.1× 65 0.9× 7 343

Countries citing papers authored by Lars Wilkinson

Since Specialization
Citations

This map shows the geographic impact of Lars Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Wilkinson more than expected).

Fields of papers citing papers by Lars Wilkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Wilkinson. The network helps show where Lars Wilkinson may publish in the future.

Co-authorship network of co-authors of Lars Wilkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Wilkinson. A scholar is included among the top collaborators of Lars Wilkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Wilkinson. Lars Wilkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Shiro, J Langer, Lars Wilkinson, et al.. (2021). Developing a health economic model for Asians with type 2 diabetes based on the Japan Diabetes Complications Study and the Japanese Elderly Diabetes Intervention Trial. BMJ Open Diabetes Research & Care. 9(1). e002177–e002177. 5 indexed citations
2.
Igarashi, Ataru, Barnaby Hunt, Lars Wilkinson, J Langer, & Richard F. Pollock. (2020). Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis. Advances in Therapy. 37(10). 4446–4457. 5 indexed citations
3.
4.
Wilkinson, Lars, Barnaby Hunt, Pierre Johansen, et al.. (2018). Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States. Diabetes Therapy. 9(3). 951–961. 16 indexed citations
5.
O’Hara, Jamie, Shaun Walsh, Charlotte Camp, et al.. (2018). The impact of severe haemophilia and the presence of target joints on health-related quality-of-life. Health and Quality of Life Outcomes. 16(1). 84–84. 93 indexed citations
6.
7.
8.
9.
O’Hara, Jamie, Shaun Walsh, Charlotte Camp, et al.. (2018). The relationship between target joints and direct resource use in severe haemophilia. Health Economics Review. 8(1). 1–1. 45 indexed citations
10.
11.
Rodrı́guez-Zepeda, Maria del Carmen, et al.. (2018). Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico. Value in Health Regional Issues. 17. 164–173. 1 indexed citations
12.
Brod, Meryl, et al.. (2017). Understanding Treatment Burden for Children Treated for Growth Hormone Deficiency. Patient. 10(5). 653–666. 38 indexed citations
13.
Brod, Meryl, et al.. (2017). Understanding burden of illness for child growth hormone deficiency. Quality of Life Research. 26(7). 1673–1686. 35 indexed citations
14.
Brod, Meryl, et al.. (2016). Assessing Disease and Treatment Burden for Young Children with Growth Hormone Deficiency (GHD). 86. 1 indexed citations
15.
16.
Mazza, Giuseppe, et al.. (2016). The Impact of Haemophilia Complications on Health-Related Quality of Life for Adults with Severe Haemophilia. Value in Health. 19(7). A593–A593. 3 indexed citations
17.
Carroll, Liz, et al.. (2016). The Relationship Between Target Joints And Non-Drug Direct Costs In Severe Haemophilia. Value in Health. 19(7). A584–A584.
18.
19.
20.
Moore, Paul A., et al.. (2000). Oral transmucosal fentanyl pretreatment for outpatient general anesthesia.. PubMed. 47(2). 29–34. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miranda Pans Breakdown of academic impact, for papers by Maja Miloslavsky Breakdown of academic impact, for papers by Hanan Azzam Breakdown of academic impact, for papers by Kung‐Ting Kao Breakdown of academic impact, for papers by Julie M. Cessna Breakdown of academic impact, for papers by Yunwen Xu Breakdown of academic impact, for papers by Jesse Fishman Breakdown of academic impact, for papers by Dennis Meletiche Breakdown of academic impact, for papers by Eleni Ι. Kalogirou Breakdown of academic impact, for papers by K Segnestam
Rankless by CCL
2026